Some previous studies have linked the diabetes medication pioglitazone to bladder cancer. They are used in the treatment of type 2 diabetes, however their use, has been questioned owing to safety concerns, including preclinical studies showing male rats overexposed to pioglitazone were at increased risk of bladder cancer.

READ FULL ARTICLE Curated publisher From Medical News Today